相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Variability in short-wavelength automated perimetry among peri- or postmenopausal women: a dependence on phyto-oestrogen consumption?
Alvin Eisner et al.
ACTA OPHTHALMOLOGICA (2011)
The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum
P. E. Lonning
ANNALS OF ONCOLOGY (2011)
Identifying Factors Associated With Falls in Postmenopausal Breast Cancer Survivors: A Multi-Disciplinary Approach
Kerri M. Winters-Stone et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2011)
Biochemical and molecular mechanisms of action of bisphosphonates
Michael J. Rogers et al.
BONE (2011)
Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
Rebecca L. Sedjo et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
Dawn L. Hershman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Dawn L. Hershman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Effect of Endocrine Therapies on Bone in Breast Cancer Patients
R. J. Santen
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Brain-Generated Estradiol Drives Long-Term Optimization of Auditory Coding to Enhance the Discrimination of Communication Signals
Liisa A. Tremere et al.
JOURNAL OF NEUROSCIENCE (2011)
Mucous Membrane Graft for Cicatricial Ectropion in Lamellar Ichthyosis: An Approach Revisited
Sameera Nayak et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
Estrogen Receptor Beta Gene Polymorphism and lntraocular Pressure Elevation in Female Patients With Primary Open-Angle Glaucoma
Fumihiko Mabuchi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Efficacy and cardiac safety of adjuvant trastuzumab-based chemotherapy regimens for HER2-positive early breast cancer
R. B. Costa et al.
ANNALS OF ONCOLOGY (2010)
Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer
Katrina Bauer et al.
BMC CANCER (2010)
Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva
Christine Bouchardy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?
Omar S. Din et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
S-J Dawson et al.
BRITISH JOURNAL OF CANCER (2010)
Breast Cancer in Men in the United States A Population-Based Study of Diagnosis, Treatment, and Survival
Linda C. Harlan et al.
CANCER (2010)
Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer
C. J. H. van de Velde et al.
CANCER TREATMENT REVIEWS (2010)
Supportive care for patients with early breast cancer
Laura Garcia-Estevez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Changes to Adjuvant Systemic Therapy in Breast Cancer: A Decade in Review
Christina A. Saurel et al.
CLINICAL BREAST CANCER (2010)
Ocular Adverse Effects of Common Psychotropic Agents A Review
Sami Richa et al.
CNS DRUGS (2010)
Optimizing the management of HER2-positive early breast cancer: the clinical reality
Su. Verma et al.
Current Oncology (2010)
Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey
S. Saibil et al.
Current Oncology (2010)
Managing the toxicities of the aromatase inhibitors
Joanne E. Mortimer
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2010)
Gender and glaucoma: what we know and what we need to know
Thasarat S. Vajaranant et al.
CURRENT OPINION IN OPHTHALMOLOGY (2010)
The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer
Donald P. McDonnell et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Retinal function in patients treated with tamoxifen
Sung Eun Song Watanabe et al.
DOCUMENTA OPHTHALMOLOGICA (2010)
Estrogen receptor beta protects against in vivo injury in RPE cells
Sharon J. Elliot et al.
EXPERIMENTAL EYE RESEARCH (2010)
An investigation of the visual disturbances experienced by patients on clomiphene citrate
Lyne Racette et al.
FERTILITY AND STERILITY (2010)
Lack of evidence for fracture prevention in early breast cancer bisphosphonate trials: A meta-analysis
Antonis Valachis et al.
GYNECOLOGIC ONCOLOGY (2010)
Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid
I. R. Reid et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Cystoid Macular Edema Secondary to nab-Paclitaxel Therapy
Conleth G. Murphy et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study
Michael Untch et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
Larissa A. Korde et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'
R. B. Raffa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Association of CYP2D6 Single-Nucleotide Polymorphism with Response to Ophthalmic Timolol in Primary Open-Angle Glaucoma-A Pilot Study
Hongzhi Yuan et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
Impact of aromatase inhibitors on bone health in breast cancer patients
Jurgen Geisler et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
Philippe L. Bedard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Cognitive changes associated with endocrine therapy for breast cancer
Kunal Agrawal et al.
MATURITAS (2010)
Menopausal arthralgia: Fact or fiction
Malgorzata Magliano
MATURITAS (2010)
Male breast cancer: An update in diagnosis, treatment and molecular profiling
Susan Onami et al.
MATURITAS (2010)
Hormone therapy and intraocular pressure in nonglaucomatous eyes
Naing L. Tint et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer.
Miguel Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Women and Bone Health: Maximizing the Benefits of Aromatase Inhibitor Therapy
Shou-Ching Tang
ONCOLOGY (2010)
Simulated Visual Impairment Leads to Cognitive Slowing in Older Adults
Joanne Wood et al.
OPTOMETRY AND VISION SCIENCE (2010)
PATHOGENESIS OF RHEGMATOGENOUS RETINAL DETACHMENT Predisposing Anatomy and Cell Biology
Danny Mitry et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Adjuvant Hormonal Therapy for Early-Stage Breast Cancer
Harold J. Burstein et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2010)
CYP2D6 Polymorphisms and Tamoxifen Metabolism: Clinical Relevance
Michaela J. Higgins et al.
CURRENT ONCOLOGY REPORTS (2010)
Estrogen Receptor Neurobiology and its Potential for Translation into Broad Spectrum Therapeutics for CNS Disorders
Zoe Hughes et al.
Current Molecular Pharmacology (2010)
An Objective Approach to Dry Eye Disease Severity
Benjamin D. Sullivan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Postmenopausal Hormone Therapy Increases Retinal Blood Flow and Protects the Retinal Nerve Fiber Layer
Micheline C. Deschenes et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Inverse Association of Female Hormone Replacement Therapy with Age-Related Macular Degeneration and Interactions with ARMS2 Polymorphisms
Digna R. Velez Edwards et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Endothelial Nitric Oxide Synthase Gene Variants and Primary Open-Angle Glaucoma: Interactions with Sex and Postmenopausal Hormone Use
Jae Hee Kang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Hearing sensitivity in women following chemotherapy treatment for breast cancer: Results from a pilot study
V. Jenkins et al.
BREAST (2009)
Vitreo-retinal traction and anastrozole use
Alvin Eisner et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Chemotherapy for early-stage breast cancer: a brief history
M. Verrill
BRITISH JOURNAL OF CANCER (2009)
Patient Adherence and Persistence With Oral Anticancer Treatment
Kathryn Ruddy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Strategies to Decrease Taxanes Toxicities in the Adjuvant Treatment of Early Breast Cancer
Shou-Ching Tang
CANCER INVESTIGATION (2009)
Microtubule dynamics as a target in oncology
April L. Risinger et al.
CANCER TREATMENT REVIEWS (2009)
Visual Impairment in Myopic Patients With Breast Cancer Receiving Adjuvant Therapy With Aromatase Inhibitors
Richard J. Epstein
CLINICAL BREAST CANCER (2009)
Enhancing the Efficacy of Hormonal Agents with Selected Targeted Agents
Stephen R. D. Johnston
CLINICAL BREAST CANCER (2009)
A 2009 Update on the Treatment of Patients with Hormone Receptor-Positive Breast Cancer
Susan J. Cleator et al.
CLINICAL BREAST CANCER (2009)
Pharmacogenomics of Tamoxifen Therapy
Hiltrud Brauch et al.
CLINICAL CHEMISTRY (2009)
Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer
Philippe L. Bedard et al.
CURRENT CANCER DRUG TARGETS (2009)
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
R. J. Santen et al.
ENDOCRINE REVIEWS (2009)
Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: The 'personalised' approach?
Hiltrud Brauch et al.
EUROPEAN JOURNAL OF CANCER (2009)
Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?
R. E. Coleman
EUROPEAN JOURNAL OF CANCER (2009)
Segregation of short-wavelength-sensitive (S) cone signals in the macaque dorsal lateral geniculate nucleus
Sujata Roy et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
The NSABP Study of Tamoxifen and Raloxifene (STAR) trial
Victor G. Vogel
Expert Review of Anticancer Therapy (2009)
Bisphosphonate-associated adverse events
Peter D. Papapetrou
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE Trial
Emanuela Rossi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sonographic and Electrodiagnostic Evaluations in Patients With Aromatase Inhibitor-Related Arthralgia
Omer Dizdar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Newer Antidepressants and Gabapentin for Hot Flashes: An Individual Patient Pooled Analysis
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
Stephen Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cytochrome Oxidase 2D6 Gene Polymorphism in Primary Open-Angle Glaucoma With Various Effects to Ophthalmic Timolol
Yangfan Yang et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Light-induced toxic effects of tamoxifen: A chemotherapeutic and chemopreventive agent
Shuguang Wang et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY (2009)
Image-Detected Breast Cancer: State-of-the-Art Diagnosis and Treatment
Melvin J. Silverstein et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Structural basis for androgen specificity and oestrogen synthesis in human aromatase
Debashis Ghosh et al.
NATURE (2009)
Cyclophosphamide and cancer: golden anniversary
Ashkan Emadi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Aromatase inhibitors in breast cancer
Stephen Hiscox et al.
MATURITAS (2009)
Re: Upper and Lower System Nasolacrimal Duct Stenosis Secondary to Paclitaxel
Aaron Savar et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2009)
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study
Barbara Collins et al.
PSYCHO-ONCOLOGY (2009)
Mechanism-based categorization of aromatase inhibitors: a potential discovery and screening tool
P. I. Petkov et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2009)
Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment
Alvaro Pinto Marin et al.
SOUTHERN MEDICAL JOURNAL (2009)
Recent advances in systemic therapy New diagnostics and biological predictors of outcome in early breast cancer
Catherine Oakman et al.
BREAST CANCER RESEARCH (2009)
Vitreomacular traction and exudative age-related macular degeneration
Stephan Schulze et al.
ACTA OPHTHALMOLOGICA (2008)
The role of abnormal vitreomacular adhesion in age-related macular degeneration: Spectral optical coherence tomography and surgical results
Francesca Mojana et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Cystoid Macular Edema Secondary to Albumin-Bound Paclitaxel Therapy
Stacy V. Smith et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Menopausal and reproductive factors and risk of age-related macular degeneration
Diane Feskanich et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Breast cancer in men - Should aromatase inhibitors become first-line hormonal treatment?
Ina C. Nordman et al.
BREAST JOURNAL (2008)
Exploring the anti-tumour activity of bisphosphonates in early breast cancer
M. C. Winter et al.
CANCER TREATMENT REVIEWS (2008)
Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions
Paul E. Goss et al.
CLINICAL BREAST CANCER (2008)
Unraveling the Biologic and Clinical Complexities of HER2
John W. Park et al.
CLINICAL BREAST CANCER (2008)
Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer
Mitch Dowsett et al.
CLINICAL CANCER RESEARCH (2008)
Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies
S. B. Park et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Macular holes: vitreoretinal relationships and surgical approaches
J. Bainbridge et al.
EYE (2008)
Non-genomic actions of estrogens and their interaction with genomic actions in the brain
Nandini Vasudevan et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2008)
Major depression after breast cancer: a review of epidemiology and treatment
Jesse R. Fann et al.
GENERAL HOSPITAL PSYCHIATRY (2008)
Advances in adjuvant endocrine therapy for postmenopausal women
Nancy U. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome
Leilani Morales et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Aromatase in the brain: Not just for reproduction anymore
L. M. Garcia-Segura
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Transmission of blue (S) cone signals through the primate lateral geniculate nucleus
C. Tailby et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Contribution of estrogen receptors α and β to the effects of estradiol in the brain
M. Morissette et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
fMRI measurements of color in macaque and human
Alex Wade et al.
JOURNAL OF VISION (2008)
Molecular structural characteristics of estrogen receptor modulators as determinants of estrogen receptor selectivity
S. Agatonovic-Kustrin et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial
Jack Cuzick et al.
LANCET ONCOLOGY (2008)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
Norman Williams
LANCET ONCOLOGY (2008)
Breast cancer imaging: A perspective for the next decade
Andrew Karellas et al.
MEDICAL PHYSICS (2008)
Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole
Adam Brufsky et al.
ONCOLOGIST (2008)
Tamoxifen retinopathy: a case series of clinical and functional data
C. Ritter et al.
OPHTHALMOLOGE (2008)
Retinal Hemorrhages in Anastrozole Users
ALVIN EISNER et al.
OPTOMETRY AND VISION SCIENCE (2008)
Long-term incidence of dry eye in an older population
Scot E. Moss et al.
OPTOMETRY AND VISION SCIENCE (2008)
Regulation of retinal blood flow in health and disease
Constantin J. Pournaras et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2008)
The color appearance of stimuli detected via short-wavelength-sensitive cones: Comparisons with visual adaptation and visual field data for peri- or post-menopausal women under 70 years of age
Alvin Eisner et al.
VISION RESEARCH (2008)
Acute retinal pigment epithelial detachment secondary to pamidronate administration
Constantin A Dasanu et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2008)
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy
David Cella et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Adherence to oral endocrine therapy for breast cancer: A nursing perspective
Christine Miaskowski et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2008)
Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors
Alvin Eisner et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Signaling by Estrogens
Boris J. Cheskis et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Chemobrain: is systemic chemotherapy neurotoxic?
Sophie Taillibert et al.
CURRENT OPINION IN ONCOLOGY (2007)
Posterior vitreomacular adhesion: A potential risk factor for exudative age-related macular degeneration?
Ilse Krebs et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen
Eric A. Ariazi et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer
Catherine E. Jansen et al.
ONCOLOGY NURSING FORUM (2007)
Role of gonadotropin-releasing hormone analog in the management of male metastatic breast cancer is uncertain
Marian J. E. Mourits et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quality of life issues in relation to the aromatase inhibitor
Lesley Fallowfield
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Expression and function of cytochrome P450 in brain drug metabolism
R. P. Meyer et al.
CURRENT DRUG METABOLISM (2007)
Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use
Solange Rios Salomao et al.
CURRENT EYE RESEARCH (2007)
Estrogen receptor α gene polymorphisms associated with incident aging macula disorder
Sharmila S. Boekhoorn et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel
Emily McCartney et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2007)
Neuroprotective effect of 17β-estradiol against N-methyl-D-aspartate-induced retinal neurotoxicity via p-ERK induction
Yasuhiro Hayashi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications
Grigorij Kogan et al.
BIOTECHNOLOGY LETTERS (2007)
Impact of dry eye syndrome on vision-related quality of life
Biljana Miljanovic et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Acute effects of estrogen on neuronal physiology
Catherine S. Woolley
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2007)
Ophthalmic timolol: Plasma concentration and systemic cardiopulmonary effects
T. Nieminen et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2007)
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer
V. Craig Jordan et al.
STEROIDS (2007)
Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs)
Musiliyu A. Musa et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer
Susanne Briest et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Contrasting blue-on-yellow with white-on-white visual fields: Roles of visual adaptation for healthy peri- or postmenopausal women younger than 70 years of age
Alvin Eisner et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Risk factors for posterior vitreous detachment: A case-control study
Jean Y. Chuo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
What clinicians need to know about antioestrogen resistance in breast cancer therapy
Amalia Milano et al.
EUROPEAN JOURNAL OF CANCER (2006)
Ovarian feedback, mechanism of action and possible clinical implications
Ioannis E. Messinis
HUMAN REPRODUCTION UPDATE (2006)
Reversal of resistance to oxazaphosphorines
Jing Zhang et al.
CURRENT CANCER DRUG TARGETS (2006)
Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel
Bita Esmaeli et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The color appearance of stimuli detected via short-wavelength-sensitive cones for breast cancer survivors using tamoxifen
A Eisner et al.
VISION RESEARCH (2006)
Peripheral neuropathy induced by microtubule-stabilizing agents
JJ Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Paradoxical increase of visual impairment with punctal occlusion in a patient with mild dry eye
Shizuka Koh et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2006)
Corticosteroid-induced glaucoma: a review of the literature
JP Kersey et al.
EYE (2006)
Small optic cup sizes among women using tamoxifen: Assessment with scanning laser ophthalmoscopy
A Eisner et al.
CURRENT EYE RESEARCH (2006)
Electrophysiological evaluation of visual pathways in paclitaxel-treated patients
V Scaioli et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Review: Aromatase inhibitors for ovulation induction
RF Casper et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel
M Tsalic et al.
MEDICAL ONCOLOGY (2006)
Ovarian feedback, mechanism of action and possible clinical implications
Ioannis E. Messinis
HUMAN REPRODUCTION UPDATE (2006)
Taxane therapy for early stage breast cancer
Jean-Marc Nabholtz et al.
WOMENS HEALTH (2006)
Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs
P Breedveld et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Docetaxel-associated epiphora
Polly E. Kintzel et al.
PHARMACOTHERAPY (2006)
Adjuvant systemic therapy for male breast carcinoma
SH Giordano et al.
CANCER (2005)
Is there recent progress in the estimation of the postmortem interval by means of thanatochemistry?
B Madea
FORENSIC SCIENCE INTERNATIONAL (2005)
Menopause and dry eye. A possible relationship
P Versura et al.
GYNECOLOGICAL ENDOCRINOLOGY (2005)
Endocrine effects of aromatase inhibitors and inactivators in vivo: Review of data and method limitations
J Geisler et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Specializations for chromatic and temporal signals in human visual cortex
JJ Liu et al.
JOURNAL OF NEUROSCIENCE (2005)
Menstrual cycle-dependent changes in visual field analysis of healthy women
Y Akar et al.
OPHTHALMOLOGICA (2005)
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
A Howell et al.
LANCET (2005)
Association of tamoxifen (TAM) and TAM metabolite concentrations with self-reported side effects of TAM in women with breast cancer
L Gallicchio et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Subcellular distribution of native estrogen receptor α and β subtypes in cultured human lens epithelial cells
PR Cammarata et al.
EXPERIMENTAL EYE RESEARCH (2004)
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
RC Coombes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Dry eye signs and symptoms in women with premature ovarian failure
JA Smith et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Pathologic findings from the national surgical adjuvant breast and bowel project - Twelve-year observations concerning lobular carcinoma in situ
ER Fisher et al.
CANCER (2004)
Tamoxifen and cataracts: a null association
BD Bradbury et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Functional vision with cataracts of different morphologies: Comparative study
E Stifter et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2004)
Detection of oestrogen receptors (ER) α and β in conjunctiva, lacrimal gland, and tarsal plates
H Spelsberg et al.
EYE (2004)
Visual sensitivity across the menstrual cycle
A Eisner et al.
VISUAL NEUROSCIENCE (2004)
Short wavelength automated perimetry and tamoxifen use
A Eisner et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study
V Jenkins et al.
PSYCHO-ONCOLOGY (2004)
Posterior vitreous detachment: Clinical correlations
SS Hayreh et al.
OPHTHALMOLOGICA (2004)
Tamoxifen optic neuropathy
SM Colley et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
Timing of menopause and patterns of menstrual bleeding
M Weinstein et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study
M Parkkari et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2003)
Kinetics of inhibition of glutamate uptake by antioestrogens
H Mäenpää et al.
PHARMACOLOGY & TOXICOLOGY (2003)
Sources of estrogen and their importance
ER Simpson
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Estrogen receptor expression in meibomian glands and its correlation with age and dry-eye parameters
C Auw-Haedrich et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2003)
Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy
B Esmaeli et al.
CANCER (2003)
Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive-synaptic connections
S Kaja et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group
M Martin et al.
ANNALS OF ONCOLOGY (2003)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Ocular surface, ocular adnexal, and lacrimal complications associated with the use of systemic 5-fluorouracil
AS Eiseman et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2003)
Cystic maculopathy with normal capillary permeability secondary to docetaxel
BA Teitelbaum et al.
OPTOMETRY AND VISION SCIENCE (2003)
Tamoxifen: A most unlikely pioneering medicine
VC Jordan
NATURE REVIEWS DRUG DISCOVERY (2003)
Scleritis and other ocular side effects associated with pamidronate disodium
FW Fraunfelder et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium
ME Marin-Castano et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Macular hole and myopic refraction
H Kobayashi et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Inhibitory effects of the antiestrogen agent clomiphene on cardiac sarcolemmal anionic and cationic currents
JJ Borg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Elucidation of the molecular mechanism of action of selective estrogen receptor modulators
DP McDonnell et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: An update
A Hemeryck et al.
CURRENT DRUG METABOLISM (2002)
Hormone replacement therapy and dry eye syndrome
DA Schaumberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Presence of oestrogen receptor type β in human retina
C Munaut et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2001)
DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology
F Labrie et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2001)
Expression of sex steroid hormone receptors in human cornea
T Suzuki et al.
CURRENT EYE RESEARCH (2001)
Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer
K Holli et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Nonsurgical management of macular hemorrhage secondary to retinal artery macroaneurysms
CM McCabe et al.
ARCHIVES OF OPHTHALMOLOGY (2000)
Structural macromolecules and supramolecular organisation of the vitreous gel
PN Bishop
PROGRESS IN RETINAL AND EYE RESEARCH (2000)
Identification of androgen, estrogen and progesterone receptor mRNAs in the eye
LA Wickham et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2000)
Reliability and validity of the ocular surface disease index
RM Schiffman et al.
ARCHIVES OF OPHTHALMOLOGY (2000)
Docetaxel administered on a weekly basis for metastatic breast cancer
HJ Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Lacrimal canalicular stenosis associated with systemic 5-fluorouracil therapy
S Prasad et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2000)
Immunohistochemical evidence for estrogen receptors in meibomian glands
B Esmaeli et al.
OPHTHALMOLOGY (2000)
Eye problems in breast cancer patients treated with tamoxifen
A Paganini-Hill et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)